Search Clinical Trials Search
Clinical Trials
× ...
Sort & Filter
Sort by
Specialty

Disease or Condition

Age Group


Drug/Medication


309 results found


Urinary Bladder

Bladder Cancer: TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical BCG

This study focuses on individuals who have a diagnosis of high-risk, non-muscle invasive bladder cancer (also referred to as HR-NMIBC or urothelial cancer). The purpose of the study is to compare the effects of ...


Hodgkin's Lymphoma, Leukemia, not otherwise specified, Leukemia, other, Lymphoid Leukemia ...

Collecting and Combining Autologous Hematopoietic Stem Cells With (CAR) T-Cell Therapy in Hematological Malignancies

The purpose of this study is to assess the impact of adding blood stem cells to CAR T-cell therapy in an effort to improve cancer treatment. CAR T-cell therapy is a type of treatment in ...


Bones and Joints, Breast, Cervix, Colon, Kidney, Liver, Lung, Melanoma ...

PARG Inhibitor IDE161 in Advanced Solid Tumors

This study focuses on individuals who have a solid tumor cancer (not a blood cancer) that has worsened and has not responded to at least one prior cancer treatment. The purpose of the study is ...


Other Hematopoietic

SWOG,S2207, PhII, Randomized, Large B-Cell Lymphoma,Targeted Therap agents + Tafasitamab-based ther

Primary Objective Safety Run-in a. To determine the recommended phase II dose of tafasitamab + lenalidomide + tazemetostat AND of tafasitamab + lenalidomide + zanubrutinib. Secondary Objective Safety Run-in a. To determine the recommended ...